Market Snapshot
  • U.S.
  • Europe
  • Asia
Ticker Volume Price Price Delta
DJIA 15,387.60 +52.30 0.34%
S&P 500 1,669.16 +2.87 0.17%
Nasdaq 3,502.12 +5.69 0.16%
Ticker Volume Price Price Delta
STOXX 50 2,821.65 -2.85 -0.10%
FTSE 100 6,803.87 +48.24 0.71%
DAX 8,472.20 +16.37 0.19%
Ticker Volume Price Price Delta
Nikkei 15,555.30 +174.25 1.13%
Hang Seng 23,366.40 -126.66 -0.54%
S&P/ASX 200 5,166.30 -13.76 -0.27%
  • Fund Type: Open-End Fund
  • Objective: Growth-Mid Cap
  • Asset Class: Equity
  • Geographic Focus: U.S.

Guggenheim U.S. Long Short Momentum Fund

+ Add to Watchlist

RYSRX:US

13.86 USD 0.02 0.14%

As of 09:29:30 ET on 05/21/2013.

Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Snapshot for Guggenheim U.S. Long Short Momentum Fund (RYSRX)

Year To Date: +7.44% 3-Month: +6.29% 3-Year: +5.67% 52-Week Range: 12.32 - 13.93
1-Month: +2.74% 1-Year: +10.76% 5-Year: -2.18% Beta vs RAY: 0.80

Mutual Fund Chart for RYSRX

No chart data available.
  • RYSRX:US 13.86
  • 1M
  • 1Y
Interactive RYSRX Chart

Previous Close

Fund Profile & Information for RYSRX

Guggenheim U.S. Long Short Momentum Fund is an open-end fund incorporated in the USA. The Fund's objective is long-term capital appreciation. The Fund invests in equity securities, but may also invest in leveraged instruments such as futures contracts, options, and swap transactions. The Fund ranks sixty-two different industries and invests in the top ranked ones.

Inception Date: 03-22-2002 Telephone: 1-301-296-5100
Managers: MICHAEL P BYRUM / MIKE DELLAPA
Web Site: www.guggenheiminvestments.com

Fundamentals for RYSRX

NAV (on 2013-05-21) 13.86
Assets (M) (on 2013-05-21) 57.41
Fund Leveraged N
Minimum Investment 2,500.00
Minimum Subsequent Investment 0.00

Dividends for RYSRX

Dividend Type Income
Dividend Frequency Annual
Last Dividend Net (on 2012-12-21) 0.02
Dividend Yield (ttm) 0.11

Fees & Expenses for RYSRX

Front Load 0.00
Back Load 0.00
Current Mgmt Fee 0.90
Redemption Fee 0.00
12b1 Fee 0.25
Expense Ratio 1.66

Top Fund Holdings for RYSRX

Filing Date: 04/30/2013
Name Position Value % of Total
Vertex Pharmaceuticals Inc 6,745 518,151 0.862%
NII Holdings Inc 52,500 456,750 0.760%
Mercury General Corp 9,119 416,829 0.694%
VCA Antech Inc 17,066 411,291 0.685%
Biogen Idec Inc 1,838 402,393 0.670%
United Therapeutics Corp 6,025 402,350 0.670%
Bunge Ltd 5,558 401,343 0.668%
Delta Air Lines Inc 23,256 398,608 0.663%
Engility Holdings Inc 16,634 398,551 0.663%
T-Mobile US Inc 16,700 395,456 0.658%

Quotes delayed, except where indicated otherwise. Mutual fund NAVs include dividends. All prices in local currency. Time is ET.

Sponsored Financial Commentaries

Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil